GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NDT Pharmaceuticals Inc (OTCPK:NDTP) » Definitions » Volatility

NDT Pharmaceuticals (NDT Pharmaceuticals) Volatility : 2683.92% (As of Jun. 22, 2024)


View and export this data going back to 2006. Start your Free Trial

What is NDT Pharmaceuticals Volatility?

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2024-06-22), NDT Pharmaceuticals's Volatility is 2683.92%.


Competitive Comparison of NDT Pharmaceuticals's Volatility

For the Biotechnology subindustry, NDT Pharmaceuticals's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NDT Pharmaceuticals's Volatility Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NDT Pharmaceuticals's Volatility distribution charts can be found below:

* The bar in red indicates where NDT Pharmaceuticals's Volatility falls into.



NDT Pharmaceuticals  (OTCPK:NDTP) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * 12
= 1/(n-1) ∑(Ri - R')^2 * 12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NDT Pharmaceuticals  (OTCPK:NDTP) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.


NDT Pharmaceuticals Volatility Related Terms

Thank you for viewing the detailed overview of NDT Pharmaceuticals's Volatility provided by GuruFocus.com. Please click on the following links to see related term pages.


NDT Pharmaceuticals (NDT Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
7325 Oswego Road, Liverpool, NY, USA, 13090
NDT Pharmaceuticals Inc is a biotechnology company focused on developing revolutionary therapies for severe neurological disorders associated with traumatic brain injury. Its Nanoscale Particle Complex (NPC) technology represents the leading edge of phospholipid-based nano-encapsulation delivery systems (less than 100 nanometers in diameter; mean diameter of 40 nanometers in current liquid product samples with the capability to engineer significantly smaller nanocarrier particles) that create instant delivery of payloads into the bloodstream, beginning through the membranes of the mouth.
Executives
Francisco Kent Carasquero director, officer: Secretary 1057 EAST 21ST AVENUE, CANADA, VANCOUVER BC A1 V5V 1S6

NDT Pharmaceuticals (NDT Pharmaceuticals) Headlines

No Headlines